These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 415750

  • 1. Studies of HLA antigens in multiple sclerosis.
    Jersild C.
    Boll Ist Sieroter Milan; 1978 Jan 31; 56(6):516-30. PubMed ID: 415750
    [Abstract] [Full Text] [Related]

  • 2. Association of histocompatibility haplotype HLA-A3-B7 with multiple sclerosis.
    Bertrams HJ, Kuwert EK.
    J Immunol; 1976 Nov 31; 117(5 Pt.2):1906-12. PubMed ID: 993587
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. HLA antigen segregation analysis in multiple sclerosis (MS) families.
    Bertrams J, Kuwert E.
    Z Immunitatsforsch Immunobiol; 1976 Nov 31; 152(3):200-8. PubMed ID: 1007375
    [Abstract] [Full Text] [Related]

  • 5. [HLA typing and insulin antibody production in insulin-dependent diabetics].
    Bruni B, Barolo P, Gadaleta G, Gamba Ansaldi S, Grassi G, Zerbinati A, Molinatti M, Salvetti E.
    Ann Osp Maria Vittoria Torino; 1984 Nov 31; 27(7-12):185-213. PubMed ID: 6443704
    [Abstract] [Full Text] [Related]

  • 6. HLA associations with multiple sclerosis in Sicily and Malta.
    Elian M, Alonso A, Awad J, Dean G, Okoye R, Sachs J, Savettieri G, Vassallo L, Festenstein H.
    Dis Markers; 1987 Jun 31; 5(2):89-99. PubMed ID: 3509722
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Disseminated sclerosis. Possible correlation between clinical forms and HLA groups (author's transl)].
    Madigand M, Fauchet R, Oger J, Sabouraud O.
    Nouv Presse Med; 1981 Jun 27; 10(28):2349-52. PubMed ID: 7267340
    [Abstract] [Full Text] [Related]

  • 9. In search of marker for genetic susceptibility to reflux nephropathy.
    Torres VE, Moore SB, Kurtz SB, Offord KP, Kelalis PP.
    Clin Nephrol; 1980 Nov 27; 14(5):217-22. PubMed ID: 6939514
    [Abstract] [Full Text] [Related]

  • 10. HLA antigens in multiple sclerosis in Alsace.
    Rumbach L, Tongio MM, Warter JM, Marescaux C, Grange D, Mayer S, Collard M.
    Biomed Pharmacother; 1985 Nov 27; 39(7):385-9. PubMed ID: 3830266
    [Abstract] [Full Text] [Related]

  • 11. Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis.
    Harbo HF, Lie BA, Sawcer S, Celius EG, Dai KZ, Oturai A, Hillert J, Lorentzen AR, Laaksonen M, Myhr KM, Ryder LP, Fredrikson S, Nyland H, Sørensen PS, Sandberg-Wollheim M, Andersen O, Svejgaard A, Edland A, Mellgren SI, Compston A, Vartdal F, Spurkland A.
    Tissue Antigens; 2004 Mar 27; 63(3):237-47. PubMed ID: 14989713
    [Abstract] [Full Text] [Related]

  • 12. [HLA and familial multiple sclerosis].
    Barroche G, Perrier P, Raffoux C, Gehin P, Streiff F, Weber M.
    Rev Neurol (Paris); 1986 Mar 27; 142(10):738-45. PubMed ID: 3823705
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Immunogenetics of multiple sclerosis].
    Clanet M, Cambon-Thomsen A, Rascol A.
    Pathol Biol (Paris); 1987 Mar 27; 35(3):299-302. PubMed ID: 3295695
    [Abstract] [Full Text] [Related]

  • 15. [Immunogenetic markers of disseminated sclerosis in western Siberia].
    Prokof'ev VF, Gribacheva IA, Konenkov VI, Doronin BM, Voronova IA.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988 Mar 27; 88(12):49-52. PubMed ID: 3245376
    [Abstract] [Full Text] [Related]

  • 16. Gene-environment interactions between HLA B7/A2, EBV antibodies are associated with MRI injury in multiple sclerosis.
    Zivadinov R, Weinstock-Guttman B, Zorzon M, Uxa L, Serafin M, Bosco A, Bratina A, Maggiore C, Grop A, Tommasi MA, Srinivasaraghavan B, Ramanathan M.
    J Neuroimmunol; 2009 Apr 30; 209(1-2):123-30. PubMed ID: 19232441
    [Abstract] [Full Text] [Related]

  • 17. Familial multiple sclerosis: clinical, histocompatibility, and viral serological studies.
    Eldridge R, McFarland H, Sever J, Sadowsky D, Krebs H.
    Ann Neurol; 1978 Jan 30; 3(1):72-80. PubMed ID: 418737
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. HLA-DR beta, -DQ alpha, and -DQ beta restriction fragment length polymorphisms in multiple sclerosis.
    Haegert DG, Michaud M, Schwab C, Tansey C, Décary F, Francis G.
    J Neurosci Res; 1989 May 30; 23(1):46-54. PubMed ID: 2568496
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.